Standard BioTools Inc (NAS:LAB)
$ 2.4 -0.01 (-0.41%) Market Cap: 909.27 Mil Enterprise Value: 892.58 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 70/100

Q4 2023 Standard BioTools Inc Earnings Call Transcript

Feb 28, 2024 / 09:30PM GMT
Release Date Price: $2.37 (+1.28%)
Operator

Good day, everyone, and welcome to Standard BioTools, Inc. fourth-quarter and full-year 2023 financial results conference call. As a reminder, this conference is being recorded. It's now my pleasure to introduce your host, David Holmes, from Investor Relations.

David, please go ahead.

David Holmes
Standard BioTools Inc - Investor Relations

Thank you, operator, and good afternoon, everyone. Welcome to Standard BioTools's fourth-quarter and full-year 2023 earnings conference call. Leading the call today is Michael Egholm, President and Chief Executive Officer; Jeff Black, Chief Financial Officer; and Adam Taich, Chief Strategy Officer.

At the close of market today, February 28, 2024, Standard BioTools released its financial results for the quarter and fiscal year ended December 31, 2023. During this call, we will review our results and provide commentary on our financial and operational performance, 2024 outlook, market trends, and strategic initiatives.

During the call, we will make forward-looking statements about events and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot